Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Cheng, Xiangdong; Wu, Dan; Xu, Nong; Chen, Luchuan; Yan, Zhilong; Chen, Ping; Zhou, Lei; Yu, Jianfa; Cui, Jiuwei; Li, Wei; Wang, Chang; Feng, Wenming; Wei, Yunhai; Yu, Pengfei; Du, Yian; Ying, Jieer; Xu, Zhiyuan; Yang, Litao; Zhang, Yunli

doi:10.1186/s12885-020-07772-7

BMC Cancer

Article metrics
Last updated: Thu, 25 Apr 2024 7:40:29 Z

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Access & Citations

2177

Article Accesses
5

Web of Science
7

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com